References
- Bradbury MJ, Giracello D, Chapman D, King C, Tehrani L, Cosford NDP, Campbell U, Anderson J, Varney MA, Strack AM. Metabotropic glutamate receptor mGluR5 is a mediator of appetite and energy balance in rats and mice. Journal of Pharmacology and Experimental Therapy 2005; 313: 395–402
- Brodkin J, Busse C, Sukoff SJ, Varney MA. Anxiolytic-like activity of the mGluR5 antagonist MPEP. A comparison with diazepam and buspirone. Pharmacology and Biochemistry Behavior 2002; 73: 359–366
- Bush MT, Mazel P, Chambers J. The metabolic fate of thiobarbiturates; thiobarbital in man. Journal of Pharmacology and Experimental Therapy 1961; 134: 110–116
- Carroll FI, Smith D, Mark LC, Brand L, Perel JM. Determination of optically active thiopental, thiamylal and their metabolites in human urine. Drug Metabolism and Disposition 1977; 5: 343–354
- Cerecetto H, Gonzalez M, Seoane G, Stanko C, Piro OE, Castellano EE. Mass spectrometry of 1,2,5-oxadiazole N-oxide derivatives. Use of deuterated analogues in fragmentation pattern studies. Journal of the Brazilian Chemistry Society 2004; 15: 232–240
- Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nature Neurosciences 2001; 4: 873–874
- Chatfield DH, Hunter WH. The metabolism of acetamidothiazoles in the rat: 2-acetamino-, 2-acatamido-4-methyl- and a-acetamino-4-phenylthiazole. Biochemistry Journal 1973; 134: 869–878
- Cosford NDP, Tehrani L, Roppe J, Schweiger E, Smith ND, Anderson J, Bristow L, Brodkin J, Jiang X, McDonald I, et al. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: A potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. Journal of Medical Chemistry 2003; 46: 204–206
- Green MD, Jiang X, King C. Inhibition of human hepatic CYP isoforms by mGluR5 antagonists. Life Sciences 2004; 75: 947–953
- Grupe A, Spiteller G. Unexpected metabolites produced from chlormethiazole. Journal of Chromatography 1982; 230: 335–344
- Huber KM, Gallagher SM, Warren ST, Bear MF. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proceedings of the National Academy of Sciences, USA 2002; 99: 7746–7750
- Johansson B, Petersen EN, Arnold E. Diethylthiocarbamic acid methyl ester: A potent inhibitor of aldehyde dehydrogenase found in rats treated with disulfiram or diethyldithiocarbamic acid methyl ester. Biochemistry and Pharmacology 1989; 37: 1053–1059
- Mizutani T, Suzuki K. Relative hepatotoxicity of 2-(substituted phenyl) thiazoles and substituted thiobezamides in mice: Evidence for the involvement of thiabenzamides as ring cleavage metabolites in the hepatotoxicity of 2-phenylthiazoles. Toxicology Letters 1996; 85: 101–105
- Mizutani T, Toshida K, Kawazoe S. Possible role of thioformamide as a proximate toxicant in the nephrotoxicity of thabendazole and related thiazoles in glutathione-depleted mice: Structure–toxicity and metabolic studies. Chemical Research in Toxicology 1993; 6: 174–179
- Mizutani T, Toshida K, Kawazoe S. Formation of toxic metabolites from thiabendazole and other thiazoles in mice: Identification of thioamides as ring cleavage products. Drug Metabolism and Disposition 1994; 22: 750–755
- Offen CP, Frearson MJ, Wilson K, Burnett D. 4,5-Dimethylthiazole-N-oxide-S-oxide: A metabolite of chlormethiazole in man. Xenobiotica 1985; 15: 503–511
- Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Progress in Neurobiology (Oxford) 1998; 54: 581–618
- Pin JP, Acher F. The metabotropic glutamate receptors: Structure, activation mechanism and pharmacology. Current Drug Targets: CNS Neurology Disorders 2002; 1: 297–317
- Renwick AG, Pettet JL, Gruchy B, Lorina DL. The fate of [14C] trithiozine in man. Xenobiotica 1982; 12: 329–343
- Trennery PN, Waring RH. The metabolism of thioacetanilide in the rat. Xenobiotica 1983; 13: 475–482
- Wilson K, Chissick H, Fowler AM, Frearson FJ, Gittins M, Swinbourne FJ. Metabolism of benzothiazole. I. Identification of ring cleavage products. Xenobiotica 1991; 21: 1179–1183
- Yabuki M, Shimakura Ito M, Kanamura H, Iba K, Nakatasuka O. Metabolism of 4-[1-(2-fluoro-4-biphenyl)-ethyl]-2-methylaminothiazole (SM-8849), in rats. European Journal of Drug Metabolism and Disposition Pharmacokinetics 1997; 22: 25–33
- Yoon WH, Yoo JK, Lee JW, Shim CD, Lee MG. Species differences in pharmacokinetics of a hepatoprotective agent, YH-439, and its metabolites M4, M5 and M7, after intravenous and oral administration to rats, rabbits and dogs. Drug Metabolism and Disposition 1998; 26: 152–163